Gastric-Type Adenocarcinoma of the Uterine Cervix Associated with Poor Response to Definitive Radiotherapy

• Published in: Cancers 2022-12, Vol.15 (1), p.170
• Main Authors: Kuruma, Airi, Kodama, Michiko, Hori, Yumiko, Sato, Kazuaki, Fujii, Makoto, Isohashi, Fumiaki, Miyoshi, Ai, Mabuchi, Seiji, Setoguchi, Akira, Shimura, Hiroko, Goto, Takeshi, Toda, Aska, Nakagawa, Satoshi, Kinose, Yasuto, Takiuchi, Tsuyoshi, Kobayashi, Eiji, Hashimoto, Kae, Ueda, Yutaka, Sawada, Kenjiro, Morii, Eiichi, Kimura, Tadashi
• Format: Article
• Language: English
• Subjects: Adenocarcinoma; Cancer therapies; Care and treatment; Cell survival; Cervical cancer; Cervix; Chemotherapy; Classification; Estrogens; Gynecology; Human papillomavirus; Infections; Lymphatic system; Magnetic resonance imaging; Malignancy; Medical prognosis; Medical screening; Methods; Morphology; Multivariate analysis; Obstetrics; Oncology; Patient outcomes; Pelvis; Radiation therapy; Radiotherapy; Squamous cell carcinoma; Tomography; Tumors; Uterus; Vaccination; Vagina; Womens health
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers15010170

We aimed to evaluate the response to definitive radiotherapy (RT) for cervical cancer based on histological subtypes and investigate prognostic factors in adenocarcinoma (AC). Of the 396 patients treated with definitive RT between January, 2010 and July, 2020, 327 patients met the inclusion criteria, including 275 with squamous cell carcinoma (SCC) and 52 with AC restaged based on the 2018 International Federation of Gynecology and Obstetrics staging system. Patient characteristics, response to RT, and prognoses of SCC and AC were evaluated. The complete response (CR) rates were 92.4% and 53.8% for SCC and AC, respectively (p < 0.05). Three-year overall survival and progression-free survival (PFS) rates of SCC were significantly higher than those of AC (88.6% vs. 74.1%, p < 0.05 and 76.3% vs. 59.3%, p < 0.05, respectively). Among the AC population, univariate and multivariate analyses were performed to examine prognostic factors associated with non-complete response (CR). In the multivariate analysis, gastric-type adenocarcinoma (GAS) was associated with non-CR in AC (adjusted odds ratio, 12.2; 95% confidence interval 1.0−145.6; p < 0.05). The 3-year PFS rate in patients with GAS was significantly lower than that in patients with other histological types of AC (44.4% vs. 66.7%, p < 0.05). Definitive RT for cervical cancer was significantly less effective for AC than for SCC. GAS was the only independent prognostic factor associated with non-CR in AC.